OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High-density lipoproteins: A promising tool against cancer
Alice Ossoli, Anna Wolska, Alan T. Remaley, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2021) Vol. 1867, Iss. 1, pp. 159068-159068
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

HDL Functions—Current Status and Future Perspectives
Yasuhiro Endo, Masanori Fujita, Katsunori Ikewaki
Biomolecules (2023) Vol. 13, Iss. 1, pp. 105-105
Open Access | Times Cited: 38

Obesity-induced changes in cancer cells and their microenvironment: Mechanisms and therapeutic perspectives to manage dysregulated lipid metabolism
Miriam Lee‐Rueckert, Marina Canyelles, Mireia Tondo, et al.
Seminars in Cancer Biology (2023) Vol. 93, pp. 36-51
Open Access | Times Cited: 19

Analyzing the impact of metabolism on immune cells in tumor microenvironment to promote the development of immunotherapy
Yanru Long, Houhui Shi, Yuedong He, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 6

Effects of T2DM on cancer progression: pivotal precipitating factors and underlying mechanisms
Yuyuan Zhang, Yongjiang Li, Chun-Dong Xue, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 6

The Role of High-Density Lipoprotein Cholesterol in 2022
Cesare R. Sirtori, Alberto Corsini, Massimiliano Ruscica
Current Atherosclerosis Reports (2022) Vol. 24, Iss. 5, pp. 365-377
Open Access | Times Cited: 25

PLGA/TPGS nanoparticles for docetaxel delivery: the pegylation effect on nanoparticle physicochemical properties and uptake and cytotoxicity in prostate cancer cells
Lívia de Queiróz Carvalho Silva, Giovanni Loureiro Raspantini, Juliana Palma Abriata, et al.
Journal of Pharmaceutical Sciences (2025), pp. 103766-103766
Closed Access

Dyslipidaemia Is Associated with Severe Disease Activity and Poor Prognosis in Ulcerative Colitis: A Retrospective Cohort Study in China
Zhaoshi Liu, Hao Tang, Haozheng Liang, et al.
Nutrients (2022) Vol. 14, Iss. 15, pp. 3040-3040
Open Access | Times Cited: 15

Low cholesterol levels are associated with increasing risk of plasma cell neoplasm: A UK biobank cohort study
Linfeng Li, Zhengyu Yu, Jianjun Ren, et al.
Cancer Medicine (2023) Vol. 12, Iss. 22, pp. 20964-20975
Open Access | Times Cited: 9

The role of cholesterol metabolism in lung cancer
Weigang Xiu, XINGYU LIU, KAIXIN HU, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 10, pp. 1613-1621
Open Access | Times Cited: 2

HDL-cholesterol confers sensitivity of immunotherapy in nasopharyngeal carcinoma via remodeling tumor-associated macrophages towards the M1 phenotype
Fan Luo, Jia‐Xin Cao, Qun Chen, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 6, pp. e008146-e008146
Open Access | Times Cited: 2

The serum LDH level and KELIM scores are potential predictors of a benefit from bevacizumab first-line therapy for patients with advanced ovarian cancer
Yi Liu, Lin Yuan, Lin Zhang, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 2

Therapeutic and pharmacological applications of extracellular vesicles and lipoproteins
Krisztína Németh, Brachyahu Meir Kestecher, S. Ghosal, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 23, pp. 4733-4749
Open Access | Times Cited: 2

Low Serum Cholesterol Level Is a Significant Prognostic Factor That Improves CLL-IPI in Chronic Lymphocytic Leukaemia
Rui Gao, Kai‐Xin Du, Jin‐Hua Liang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7396-7396
Open Access | Times Cited: 4

Novel design of fractional cholesterol dynamics and drug concentrations model with analysis on machine predictive networks
Muhammad Junaid Ali Asif Raja, Shahzaib Ahmed Hassan, Chuan‐Yu Chang, et al.
Computers in Biology and Medicine (2024) Vol. 184, pp. 109423-109423
Closed Access | Times Cited: 1

HDL‐mediated reduction of cholesterol content inhibits the proliferation of prostate cancer cells induced by LDL: Role of ABCA1 and proteasome inhibition
Alice Ossoli, Eleonora Giorgio, Federica Cetti, et al.
BioFactors (2022) Vol. 48, Iss. 3, pp. 707-717
Open Access | Times Cited: 6

Finite-Size Effects in Simulations of Peptide/Lipid Assembly
Zack Jarin, Olivia Agolini, Richard W. Pastor
The Journal of Membrane Biology (2022) Vol. 255, Iss. 4-5, pp. 437-449
Open Access | Times Cited: 5

Gemcitabine-loaded synthetic high-density lipoprotein preferentially eradicates hepatic monocyte-derived macrophages in mouse liver with colorectal cancer metastases
Fengqin Xiong, Wen Zhang, Chao Zheng, et al.
Acta Pharmacologica Sinica (2023) Vol. 44, Iss. 11, pp. 2331-2341
Closed Access | Times Cited: 2

Establishment and validation of a nomogram model for preoperative prediction of the risk of cholangiocarcinoma with perineural invasion.
Maobing Wang, Zhaowei Sun, Qinlei Wang, et al.
PubMed (2023) Vol. 13, Iss. 11, pp. 5082-5093
Closed Access | Times Cited: 2

The associations between serum high-density lipoprotein cholesterol levels and malignant behavior in pancreatic neuroendocrine neoplasms
Quan Li, Yongkang Liu, Wenjing Cui, et al.
Lipids in Health and Disease (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 4

Differential impact of lipid profile according to neutrophil-to-lymphocyte ratio status in patients with advanced cancer treated with immunotherapy
Fabiana Perrone, Federica Pecci, Michele Maffezzoli, et al.
Immunotherapy (2024) Vol. 16, Iss. 13, pp. 859-868
Closed Access

Do metabolic factors increase the risk of thyroid cancer? a Mendelian randomization study
Weiwei Liang, Fangfang Sun
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top